D-0863-2020 Class I Terminated
FDA drug recall D-0863-2020 was initiated by Taro Pharmaceuticals U.S.A., Inc. on February 7, 2020 and is designated Class I. Reason for recall: Resuspension Problems: Two lots of Phenytoin Oral Suspension USP 125mg/5mL may coagulate and may not resuspend as per the label copy instructions. The recall status is terminated (terminated December 11, 2023). Affected quantity: 29,172 8 Fl Oz bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- March 4, 2020
- Initiation Date
- February 7, 2020
- Termination Date
- December 11, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 29,172 8 Fl Oz bottles
Product Description
Phenytoin Oral Suspension USP, 125 mg/5 mL potency, 8 fl oz (237 mL) Rx Only Mfd. by: Taro Pharmaceuticals Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A. Inc. Hawthorne, NY 10532, NDC 51672-4069-1
Reason for Recall
Resuspension Problems: Two lots of Phenytoin Oral Suspension USP 125mg/5mL may coagulate and may not resuspend as per the label copy instructions.
Distribution Pattern
Distributed Nationwide in the USA.
Code Information
Lot# 327874, 327876, Exp Dec/2020